Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1.
Besse B, Felip E, Garcia Campelo R, Cobo M, Mascaux C, Madroszyk A, Cappuzzo F, Hilgers W, Romano G, Denis F, Viteri S, Debieuvre D, Galetta D, Baldini E, Razaq M, Robinet G, Maio M, Delmonte A, Roch B, Masson P, Schuette W, Zer A, Remon J, Costantini D, Vasseur B, Dziadziuszko R, Giaccone G; ATALANTE-1 study group. Besse B, et al. Ann Oncol. 2023 Oct;34(10):920-933. doi: 10.1016/j.annonc.2023.07.006. Epub 2023 Sep 11. Ann Oncol. 2023. PMID: 37704166 Free article. Clinical Trial.
Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study.
Leal T, Kotecha R, Ramlau R, Zhang L, Milanowski J, Cobo M, Roubec J, Petruzelka L, Havel L, Kalmadi S, Ward J, Andric Z, Berghmans T, Gerber DE, Kloecker G, Panikkar R, Aerts J, Delmonte A, Pless M, Greil R, Rolfo C, Akerley W, Eaton M, Iqbal M, Langer C; LUNAR Study Investigators. Leal T, et al. Among authors: panikkar r. Lancet Oncol. 2023 Sep;24(9):1002-1017. doi: 10.1016/S1470-2045(23)00344-3. Lancet Oncol. 2023. PMID: 37657460 Clinical Trial.
When does early palliative care influence aggressive care at the end of life?
Davis MP, Vanenkevort EA, Elder A, Young A, Ordonez IDC, Wojtowicz MJ, Ellison H, Fernandez C, Mehta Z, Behm B, Digwood G, Panikkar R. Davis MP, et al. Among authors: panikkar r. Support Care Cancer. 2022 Jun;30(6):5371-5379. doi: 10.1007/s00520-022-06954-2. Epub 2022 Mar 15. Support Care Cancer. 2022. PMID: 35290511
Organizational Characteristics and Smoking Cessation Support in Community-Based Lung Cancer Screening Programs.
Bellinger C, Foley KL, Dressler EV, Kittel C, Miller DP Jr, Weaver KE, Sutfin EL, Petty WJ, Spangler J, Stone R, Anderson DM, Kehn H, Steenstra C, Panikkar R, Chiles C; Study Writing Team. Bellinger C, et al. Among authors: panikkar r. J Am Coll Radiol. 2022 Apr;19(4):529-533. doi: 10.1016/j.jacr.2022.01.014. Epub 2022 Mar 2. J Am Coll Radiol. 2022. PMID: 35247325 Free PMC article.
Patient-Centered Standards for Medically Integrated Dispensing: ASCO/NCODA Standards.
Dillmon MS, Kennedy EB, Anderson MK, Brodersen M, Cohen H, D Amato SL, Davis P, Doshi G, Genschaw S, Makhoul I, Ormsby W, Panikkar R, Peng E, Raez LE, Ronnen EA, Wimbiscus B, Reff M. Dillmon MS, et al. Among authors: panikkar r. J Clin Oncol. 2020 Feb 20;38(6):633-644. doi: 10.1200/JCO.19.02297. Epub 2019 Dec 9. J Clin Oncol. 2020. PMID: 31815576
13 results